F18.21
Inhalant dependence, in remission
Clinical Classification Guidelines
Inclusion Terms
- Inhalant use disorder, moderate, in early remission
- Inhalant use disorder, moderate, in sustained remission
- Inhalant use disorder, severe, in early remission
- Inhalant use disorder, severe, in sustained remission
Medical Intelligence & Overview
ICD-10 code F18.21 refers to a diagnosis where an individual has experienced inhalant dependence, but the condition is currently in remission. Inhalant dependence involves a compulsive need to use volatile substances, which can significantly impact one’s health and daily life. Recognizing the condition and understanding its remission status can help patients, families, and healthcare providers manage recovery and maintain long-term well-being.
Causes & Symptoms
Clinical Causes: Repeated inhalant use over time, leading to physical and psychological dependence Environmental factors such as peer influence, availability of inhalants, or social settings Underlying mental health issues like depression, anxiety, or trauma that contribute to substance use Genetic predisposition that may increase vulnerability to substance dependence Lack of awareness or education about the dangers of inhalant use
Key Symptoms: Craving or strong desire to use inhalants Failed attempts to cut down or stop inhalant use Continued inhalant use despite awareness of health problems Neglect of personal, social, or occupational responsibilities Use of inhalants in hazardous situations, such as while driving Physical symptoms like dizziness, headaches, nausea, or fatigue during use
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a clinical assessment, including patient history, physical examination, and screening for substance use behaviors. Healthcare providers evaluate signs of dependence based on criteria like the extent of use, control over use, and impact on daily functioning. In cases of remission, the assessment confirms the absence or significant reduction of inhalant use, often through self-reporting and possible corroboration from family or friends.
Treatment Protocols: While the ICD-10 code F18.21 indicates that dependence is in remission, ongoing support and management are crucial. Treatment strategies may include:
Clinical Advice & FAQs
Billing Guidance
Is F18.21 a billable ICD-10 code?
Yes, F18.21 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F18.21?
Clinical documentation must specify the nature of Inhalant dependence, in remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference